Navigation Links
Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale
Date:5/1/2012

tp://www.michaeljfox.org/living_viewpoints_newsInContext_article.cfm?ID=40">http://www.michaeljfox.org/living_viewpoints_newsInContext_article.cfm?ID=40.  

About Dyskinesia
Dyskinesia is a distressing problem for many people with PD, who report that it is one of the most difficult aspects of the disease to manage.  Because they fear developing dyskinesia, many patients wait as long as possible to begin using the drug levodopa, the gold-standard treatment for relieving the stiffness, tremors, and rigidity that are the cardinal features of PD.  Even after starting levodopa, many limit the dosage to reduce the dyskinesia, and therefore settle for a sub-optimal benefit from the best medical therapy available for their disease. 

About The Michael J. Fox Foundation
As the world's largest private funder of Parkinson's research, The Michael J. Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved therapies for those living with the condition today. The Foundation pursues its goals through an aggressively funded, highly targeted research program coupled with active global engagement of scientists, Parkinson's patients, business leaders, clinical trial participants, donors and volunteers.  In addition to funding more than $289 million in research to date, the Foundation has fundamentally altered the trajectory of progress toward a cure. Operating at the hub of worldwide Parkinson's research, the Foundation forges groundbreaking collaborations with industry leaders, academic scientists and government research funders; increases the flow of participants into Parkinson's disease clinical trials with its online tool, Fox Trial Finder; promotes Parkinson's awareness through high-profile advocacy, events and outreach; and coordinates the grassroots involvement of thousands of Team Fox members around the world. Now through December 31, 2012, all new and increased giving to The M
'/>"/>

SOURCE The Michael J. Fox Foundation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Michael J. Fox Foundation Awards Up to $3 Million to Industry Teams to Jumpstart Promising PD Drug Development
2. Michael J. Fox Foundation Commits Up to $3 Million for Clinical Trials That Can Improve Treatment of Parkinsons Disease
3. New Michael J. Fox Foundation Initiative Will Drive Development of Web-Based Tools to Increase Patient Participation in Parkinsons Clinical Trials
4. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
5. Michael J. Fox Foundation Announces $5.6-Million Award for Phase 2 Clinical Trial Studying Neuroprotective Potential of Inosine
6. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
7. Michael J. Fox Foundation Awards $2.4 Million for Validation of Nine Promising Therapeutic Targets for Parkinsons Disease
8. Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinsons Therapeutics
9. Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee
10. Michael J. Fox Foundation Funds $1.1 Million for Cutting-Edge Approaches to Parkinsons Disease Under Rapid Response Innovation Awards 2008
11. Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Md. , Aug. 29, 2014  United Therapeutics ... the U.S. District Court for the District of ... favor in the company,s case against Sandoz, Inc. regarding ... Peter Sheridan ruled that U.S. Patent No. ... and enjoined Sandoz from marketing its generic product until ...
(Date:8/29/2014)... Aug. 29, 2014  Unilife Corporation ("Unilife" or "Company") ... that it intends to release its financial results for ... 30, 2014 after market trading ends on Tuesday, September ... conference call for 4:30 p.m. U.S. EDT on Tuesday, ... a.m. AEST), to review the Company,s financial results, commercial partnerships, ...
(Date:8/29/2014)... UNION CITY, Calif. , Aug. 29, 2014 /PRNewswire/ ... products company manufacturing point-of-care blood instrumentation and consumables to ... Clint Severson , Chairman and Chief Executive Officer, ... Annual Best Ideas Conference 2014 on Tuesday, September 9, ... held at the Omni Berkshire Place Hotel in ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2
(Date:8/30/2014)... 30, 2014 Seniors Guide, the comprehensive guide ... focus on Alzheimer’s Disease, Dementia, and Memory Loss . ... public of being diagnosed with the Alzheimer’s, inspired Seniors Guide ... Be Me”. The movie, out on October 14, 2014, ... his diagnosis of the disease – which inspires a final ...
(Date:8/30/2014)... 2014 In today’s world, a good night’s ... Snoring and sleep apnea (a medical problem where the airway ... bed partners of the rest they need to face their ... snores and 20 million people in the United States alone ... and treated; and of those treated, many cannot tolerate their ...
(Date:8/30/2014)... "My niece developed a nighttime fever, and I ... fever might get worse," said an inventor from Montgomery, ... how she was doing, I developed this monitoring system." ... a child's temperature. The unit instantly alerts parents if ... medical care can be given, which is designed to ...
(Date:8/30/2014)... lead extraction (TLE) is clinically successful in more than ... Lead Extraction ConTRolled (ELECTRa) registry presented for the first ... Grazia Bongiorni, chair of the registry,s executive committee. , ... devices (CIED) implant procedures has grown in recent years. ... increased and leads are often the cause. TLE is ...
(Date:8/30/2014)... The new review published by Daily Gossip reveals ... Brimeyer, who wanted to make her guide accessible to sufferers ... now easy to find in the form of an eBook, ... author of the new method shares all her tips and ... in its review that the leaky gut syndrome can be ...
Breaking Medicine News(10 mins):Health News:Alzheimer’s Disease and Dementia Focus on Retirement Website SeniorsGuideOnline.com 2Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Transvenous lead extraction clinically successful in 98 percent of cases 2Health News:Transvenous lead extraction clinically successful in 98 percent of cases 3Health News:Leaky Gut Cure Review Reveals Unique Method to Stop Chronic Symptoms 2
... 7 MQ Associates, Inc.,("MedQuest"), a leading national provider ... third quarter and nine months ended,September 30, 2007. ... 2007, representing,a decrease of $8.1 million, or 11.9%, from ... Net revenue was $186.5 million for the nine months,ended ...
... for retinopathy laser treatment, study finds , WEDNESDAY, Nov. ... diabetes, the drug fenofibrate reduces the need for laser ... loss and blindness among working-age adults worldwide. , Australian ... ages 50-75, who received either 200 milligrams per day ...
... 7 MED3OOO, Inc., a national healthcare,management ... Molina,Healthcare of California to provide Revenue Cycle ... communications technology, and,coding services. Molina Healthcare ... managed,healthcare companies serving patients who have traditionally ...
... BURLINGTON, Mass., Nov. 7 LeMaitre Vascular,Inc. (Nasdaq: ... medical,devices and implants for the treatment of peripheral ... Adams inaugural Cardiovascular,Conference on Tuesday, November 13, 2007, ... David B. Roberts, President of LeMaitre Vascular, ...
... Changes reflect company,s focus on growth and value ... Technologies, Inc. ("EAU",or "Company") (OTC Bulletin Board: EAUI), ... Technology" to numerous industries,including food processing, agriculture, dairy ... help the organization,better meet the needs of its ...
... cholesterol-lowering drug appears to disrupt sleep patterns of some ... Sessions 2007. , The findings are significant because sleep ... adverse health consequences, such as promoting weight gain and ... the study and an associate professor of medicine and ...
Cached Medicine News:Health News:MQ Associates, Inc. Announces Results for the Third Quarter and Nine Months Ended September 30, 2007 2Health News:MQ Associates, Inc. Announces Results for the Third Quarter and Nine Months Ended September 30, 2007 3Health News:MQ Associates, Inc. Announces Results for the Third Quarter and Nine Months Ended September 30, 2007 4Health News:MQ Associates, Inc. Announces Results for the Third Quarter and Nine Months Ended September 30, 2007 5Health News:MQ Associates, Inc. Announces Results for the Third Quarter and Nine Months Ended September 30, 2007 6Health News:MQ Associates, Inc. Announces Results for the Third Quarter and Nine Months Ended September 30, 2007 7Health News:Diabetes Drug Helps Protect Patients' Eyes 2Health News:Molina Medical Group Selects MED3OOO 2Health News:EAU Technologies Announces New Chairman of the Board and Board Leadership 2Health News:EAU Technologies Announces New Chairman of the Board and Board Leadership 3Health News:EAU Technologies Announces New Chairman of the Board and Board Leadership 4Health News:Cholesterol-lowering drug linked to sleep disruptions 2
... cannula with 30 gauge, 4.76 mm tip is ... Cannula is attached to a luer lock high ... inch long), for use with high viscosity substances. ... using visco elastic materials. Flattened, angled tip of ...
20 gauge x 25 mm cannula with 30 degree x 5 mm tip. 30 gauge cannula extends into hub 2 mm from end of hub. 10 per box....
Developed for oculoplastic procedures for corneal and scleral protection. Dimensions enable protector to rest on the sclera and not on the cornea. Easily removed with Bishop-Harmon Forceps. Individua...
The moist air humidifying chamber is designed for the infusion of humidified air during phakic fluid air exchange. Sterile single-use. 10 per box. Most popular size or model....
Medicine Products: